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INTRODUCTION
Oxytocin is a neuropeptide known as the "maternal
hormone" due to its activation during pregnancy
and lactation. The role of oxytocin during preg-
nancy and lactation is to improve the function of
the reproductive and maternal behavior.1 Some
studies found that oxytocin receptors were distri-
buted in various areas in the brain2 and associated
with sexual behavior, maternal and social attitude.
They could also response to the stressor.3 Oxytocin
has anxiolytic effect and may delay the hypothala-
mus-pituitary-axis responsiveness to adrenal (HPA).
The effect is very dependent on the gender, species,
duration of therapy, and the brain areas.
During prenatal and postpartum, women have
more risk for anxiety and depression. The preva-
lence of anxiety on the postpartum period is in-
creased compared to women in the general popu-
lation. Postpartum anxiety and depression impact
to maternal and child development.4
Abstract
Objective: To know the prevalence of postpartum anxiety and de-
pression in patients who received intrapartum oxytocin.
Method: Across-sectional observational study was conducted in Dr.
Cipto Mangunkusumo hospital. Observation used Edinburgh Post-
natal Depression scale and Beck Anxiety Inventory before delivery
day, on the first and fourteenth day of postpartum.
Result: Of 112 patients, we found the prevalence of mild and mode-
rate anxiety were 94.6% and 5.4%. There were no anxiety women
before delivery and on the first day of postpartum. The prevalence
of mild and moderate anxiety on the fourteenth day of postpartum
were 83% and 16.9%. There was no severe anxiety found at those
time. On the other hand, the prevalence of postpartum depression
on the first and fourteenth day of postpartum were 31.3% and
32.1%. There was no association between exogenous oxytocin and
postpartum anxiety also depression. In multivariate analysis, we
found that women with low self image were more prone to postpar-
tum anxiety (OR 0.16, 95% CI 0.06-0.46). Meanwhile, postpartum
depression was associated significantly to self image (OR 0.17, 95%
CI 0.07-0.83), low income (OR 10.35, 95% CI 1.72-62.45) and preg-
nancy plan (OR 0.17, 95% CI 0.06-0.53)
Conclusion: The patients who received intrapartum oxytocin are
more prevalent to have mild anxiety. The prevalence of depression
before delivery day, on the first and fourteenth day of postpartum
are similar. In statistic, there is no relationship between intrapartum
oxytocin administration and postpartum anxiety or depression.
[Indones J Obstet Gynecol 2016; 4-2: 59-63]
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Abstrak
Tujuan: Mengetahui prevalensi kejadian kecemasan dan depresi pas-
camelahirkan pada pasien yang mendapat oksitosin intrapartum.
Metode: Studi observasi dengan desain potong lintang dilakukan di
RSUPN Dr. Cipto Mangunkusumo. Observasi dengan menggunakanEdinburgh Postnatal Depression scale dan Beck Anxiety Inventory se-
belum melahirkan, hari ke-1 dan 14 pascamelahirkan.
Hasil: Dari 112 pasien, prevalensi kecemasan ringan dan sedang sebe-
sar 94,6% dan 5,4%. Tidak ada yang mengalami kecemasan sebelummelahirkan dan satu hari pascamelahirkan. Prevalensi kecemasan
ringan dan sedang pada hari 14 pascamelahirkan sebesar 83% dan
16,9% dan tidak ada yang menjadi kecemasan berat. Sementara itu,prevalensi depresi pada hari ke-1 dan 14 pascamelahirkan sebesar
31,3% dan 32,1%. Tidak ada hubungan yang bermakna antara cara
pemberian, dosis kumulatif dan lama pemberian oksitosin dengan ke-cemasan dan depresi pascamelahirkan pada hari ke-1 dan 14. Dari
hasil analisis multivariat, hanya citra diri saja yang berpengaruh ter-hadap kejadian kecemasan pascamelahirkan (OR 0,16; IK 95% 0,06-
0,46). Sementara itu, depresi pascamelahirkan berhubungan dengan
citra diri (OR 0,17; IK 95% 0,01-0,83), penghasilan rendah (OR 10,35;IK 95% 1,72- 62,45) dan keinginan hamil (OR 0,17; IK 95% 0,06-0,53).
Kesimpulan: Pasien yang mendapat oksitosin intrapartum lebih se-ring mengalami kecemasan ringan. Kejadian depresi sebelum mela-
hirkan, hari ke-1 maupun 14 pascamelahirkan memiliki prevalensiyang serupa. Secara statistik, tidak ada hubungan yang bermakna an-
tara pemberian oksitosin intrapartum dengan kecemasan atau de-
presi pascamelahirkan.
[Maj Obstet Ginekol Indones 2016; 4-2: 59-63]
Kata kunci: depresi, intrapartum, kecemasan, oksitosin, pascamela-
hirkan
Correspondence: Grace Valentine. Email:grace_val2004@yahoo.com
Vol 4, No 2
April 2016 Anxiety and depression after intrapartum oxytocin  59
Various experimental studies about the role of
oxytocin to anxiety and depression have been car-
ried out on animals; however, there are only few
studies conducted in human.5,6 One study showed
that women getting exogenous oxytocin intrave-
nously and intramuscularly at birth had the de-
creased of anxiety and increased of social function
in the observation on the second day, second
month, and sixth month postpartum.7 Unfortu-
nately, there was still few studies finding the central
effect of exogenous oxytocin, especially on the anx-
iolytic and depression effects. Therefore, this study
was carried out to know the prevalence of postpar-
tum anxiety and depression in patients who re-
ceived intrapartum oxytocin and the relationship
between exogenous oxytocin to postpartum anxiety
and depression.
METHODS
This observational study was a cross-sectional de-
sign on the aterm pregnant patients planned to
vaginal birth and received oxytocin during labor in
Tangerang and Fatmawati General Hospital from
December 2013 to May 2014. The subjects who ful-
filled the inclusion criteria and agreed to participate
in the study were asked to fill out questionnaires
before and after delivery (on the first and four-
teenth day of postpartum). The questionnaire was
consisted of Beck Anxiety Inventory and the Edin-
burgh Postnatal Depression Scale (EPDS), which
had been validated and proven their reliabi-lity in
assessing anxiety and depression. The ethical com-
mittee from Faculty of Medicine University of Indo-
nesia had approved the study protocol. We con-
ducted a descriptive categorical data analysis to
look at the prevalence of postpartum anxiety and
depression in both study groups at three times
measurement. Statistical analysis was performed
with Mann-Whitney test to see the relationship
between oxytocin and postpartum anxiety also de-
pression. Multivariate analysis with stepwise logis-
tic regression analysis method was done to control
the confounding variables of age, parity, unplanned
or unwanted pregnancy, socioeconomic status, self-
image, problems in the household, as well as the
emotional and social support from her husband and
family.
RESULTS
There were 112 subjects in this study. The age of
them was ranged from 16 to 44 years old with a
median value of 29.5 years old. The majority of sub-
jects (80.4%) had secondary level, 52.7% was mul-
tipara and 78.6% had moderate self-image and
didn’t plan for this pregnancy. The delivery process
accompanied by her husband was 73 subjects
(65.2%) (Table 1).
Table 1. Characteristics of Subjects
Characteristics Total n (%)
Age, Median (years old) 29.5 (16-44)
Age group, n (%)
<20 years old 5 (4.5)
20-30 years old 56 (50)
31-40 years old 46 (41.1)
>40 years old 5 (4.5)
Education status, n (%)
Low 19 (17)
Moderate 90 (80.4)
High 3 (2.7)
Economic status, n (%)
Low 10 (9.1)
Moderate 94 (84.6)
High 8 (7.2)
Total number of pregnancies, n (%)
Primipara 40 (35.7)
Multipara 59 (52.7)
Grande multipara 13 (11.6)
Pregnancy plan
Yes 87 (77.7)
No 25 (22.3)
Self­image
Low 24 (21.4)
Moderate 88 (78.6)
Any conflict in family
Yes 8 (7.1)
No 104 (92.9)
Wanted pregnancy
Yes 101 (90.2)
No 11 (9.8)
Any husband companion during labor
Yes 73 (65.2)
No 39 (34.8)
Oxytocin
IV-IM 81 (72.3)
IM 31 (27.7)
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Cumulative dose of oxytocin
10 U 30 (26.8)
15 U 16 (14.)
20 U 1 (0.9)
>20 U 65 (58)
Duration of administration,
median (range) (hours) 6.5 (1-27)
In this study, the prevalence of mild and mode-
rate anxiety in patients who received intrapartum
oxytocin were 94.6% and 5.4%. None experienced
severe anxiety prenatal and on the first day of post-
partum. After 14 days of postpartum, patients ha-
ving moderate anxiety increased to 16.3% and no
subjects suffered from severe anxiety. In subjects
receiving oxytocin intravenously and intramuscu-
larly, the prevalence of mild and moderate anxiety
at admission were 93.8% and 6.2%. Meanwhile,
the prevalence on the fourteenth day of postpar-
tum were 85.1% and 14.8%. In subjects getting
oxytocin intramuscularly only, the prevalence of
mild and moderate anxiety at admission were
96.7% and 0.9%; and after 14 days of postpartum,
the prevalence became 77.4% and 22.7%.
In this study, we found that the prevalence of
depression at admission, 1 day and 14 days after
delivery in patients receiving intrapartum oxytocin
were 29.5%, 31.3% and 32.1% respectively. In sub-
jects who received oxytocin intravenously and in-
tramuscularly, the prevalence of postpartum de-
pression at admission, 1 day and 14 days after de-
livery were 27.1%, 33% and 34.5%, respectively.
In subjects getting oxytocin intramuscularly, the
prevalence of postpartum depression before delive-
ry day, on the first and fourteenth day of postpar-
tum were 35.4%, 25.8% and 25.8%, respectively.
We found no relationship between the mode of
administration (IV and IM or IM only), cumulative
dose and length of administration and postpartum
anxiety on the first and fourteenth day of post-
partum (Table 2 and 3).
Table 2. Relationship between Mode of Administration, Cumulative Dose, and Duration of Administration of
     Intrapartum Oxytocin on Postpartum Anxiety.
Day­1 postpartum Day­14 postpartum
Mild anxiety Moderate anxiety p Mild anxiety Moderate anxiety p
Mode of administration
Intravenous and intra-
muscular oxytocin (%) 96.3 3.7 0.21* 85.2 14.8 0.33**
Intramuscular oxytocin only (%) 90.3 9.6 77.4 22.6
Oxytocin cumulative dose (IU) 30 (10-50) 20 (10-35) 0.46** 30 (10-45) 15 (10-50) 0.32**
Duration of administration (hours) 6.5 (1-27) 12 (6-18) 0.26** 6.5 (1-18) 7.25 (6-27) 0.51**
*Fisher; **Chi-square
Table 3. Relationship between Mode of Administration, Cumulative Dose, and Duration of Administration of
     Intrapartum Oxytocin on Postpartum Depression.
Day­1 postpartum Day­14 postpartum
No depression Depression p No depression Depression p
Mode of administration
Intravenous and intra-
muscular oxytocin (%) 54 27 0.44* 53 28 0.37*
Intramuscular oxytocin only (%) 23 8 23 8
Oxytocin cumulative dose (IU) 30 (10-35) 30 (10-50) 0.15** 30 (10-35) 30 (10-50) 0.19**
Duration of administration (hours) 6.5 (1-18) 12 (2-27) 0.38** 6.5 (1-18) 10 (2-27) 0.49**
*Chi-square; **Mann-Whitney
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DISCUSSION
In this study, we found that the prevalence of de-
pression at admission, 1 day and 14 days after de-
livery in patients who received intrapartum oxyto-
cin were 29.5%, 31.3% and 32.1%; respectively.
The prevalence of postpartum depression in the
general population in other countries was varied
from 10 to 34%. The prevalence of postpartum de-
pression in Asia was between 11% and 60.8%.9
Alfiben et al. found that postpartum depression
prevalence in Dr. Cipto Mangunkusumo hospital
was 33%.10
In this study, the assessment was carried out on
the first and fourteenth day of postpartum. In a
previous study conducted by Alfiben et al. in RSCM,
they found that the EPDS evaluation at 48 hours
postpartum and 2 weeks postpartum were not sta-
tistically significantly, so they suggested to perform
only one assessment only.9 The aim of assessment
using EPDS at two weeks postpartumin in this
study was to exclude the postpartum blues which
usually happened and lasted until the two weeks
after delivery.
There were no association among the mode of
oxytocin administration, cumulative dose and
length of administration with postpartum anxiety.
These findings differred from the results by Jonas,
et al. which showed that women who got exoge-
nous oxytocin during labor either IM or IV had the
lower risk to be anxiety and aggression; as well as,
they stated that exogenous oxytocin was related to
the increased socialization, including maternal be-
havior.7 Apart from that, there were two studies
finding a negative correlation between plasma le-
vels of oxytocin and anxiolytic effects; meanwhile
it described a positive relationship between plasma
oxytocin level and positive feelings in non-preg-
nant women.11,12 Other studies also found a nega-
tive correlation between the incidence of postpar-
tum depression and oxytocin. Women with low
level of oxytocin level during pregnancy had in-
creased risk of postpartum depression. Increased
incidence of depression at 2 weeks after delivery
occurred in individuals with lower plasma oxytocin
concentration.13
Whether plasma oxytocin level can be used as a
prediction for central oxytocin level, activity level
in the brain, and its relationship with the social and
emotional behavior is still unclear. One study men-
tioned that plasma oxytocin level did not reflect the
availability of oxytocin in the central. Central oxy-
tocin release was not necessarily related to the re-
lease of oxytocin into the peripheral; therefore, the
relationship among psychological variables should
be interpreted cautiously.3,14
Neurohypophysis is a major contributor to the
plasma oxytocin level, especially during childbirth
and breastfeeding. This release is not affected by
the blood-brain barrier; this hormone is released
directly from the circuit magnoseluler into the ca-
pillary. Either endogenous or exogenous oxytocin
has a poor penetration to the blood-brain barrier.
In physiological condition, there are differences in
plasma oxytocin concentration and cerebrospinal
fluid. Level of oxytocin shows circadian cycle in the
cerebrospinal fluid, but not in the other way
around. The difference in oxytocin concentration
or release pattern in body fluid, including cerebro-
spinal fluid versus plasma, is influenced by various
peptides. In addition, oxytocin also has a short half-
life in the blood, between 3 and 9 minutes.14
Study about antidepressants or anxiolytic effect
of exogenous oxytocin is still limited. The recent
study showed that there was a negative effect from
exogenous oxytocin on depression postpartum.15,16
However, the role of exogenous oxytocin on mater-
nal behavior is quite clear, although recent evi-
dence states that the effect may still be confounded
by endogenous oxytocin level produced during the
mother-baby bonding time. In addition, individual
factors, such as variation of the oxytocin receptor
function, production of endogenous oxytocin, bon-
ding between mother and baby should be consi-
dered. These factors affect individual responsive-
ness to exogenous oxytocin. Gonadal hormone, es-
pecially estrogen also affects the regulation of
endogenous and exogenous oxytocin.17 It is still un-
known whether the administration of exogenous
oxytocin can interact with the level of endogenous
hormone oxytocin or other endogen hormone.18
CONCLUSION
The patients who received intrapartum oxytocin
are more prevalent to have mild anxiety. The pre-
valence of depression before delivery day, on the
first and fourteenth day of postpartum are similar.
In statistic, there is no relationship between intra-
partum oxytocin administration and postpartum
anxiety or depression.
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